Meyka Pro banner
TMS Co., Ltd.

TMS Co., Ltd. Fundamental Analysis (JPX: 4891.T)

4891.TJPX
HealthcareBiotechnology
¥109.00
¥1.00(0.91%)
Japanese Market opens in 10h 48m

TMS Co., Ltd. Fundamental Analysis (JPX: 4891.T)

TMS Co., Ltd. (JPX: 4891.T) shows weak financial fundamentals with a PE ratio of -5.50, profit margin of 0.00%, and ROE of -31.82%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position49.50%
PEG Ratio-0.26
Current Ratio24.16

Areas of Concern

ROE-31.82%
Operating Margin0.00%
We analyze 4891.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2.3/100

We analyze 4891.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

4891.T struggles to generate sufficient returns from assets.

ROA > 10%
-35.04%

Valuation Score

Excellent

4891.T trades at attractive valuation levels.

PE < 25
-5.50
PEG Ratio < 2
-0.26

Growth Score

Weak

4891.T faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

4891.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
24.16

Profitability Score

Weak

4891.T struggles to sustain strong margins.

ROE > 15%
-3182.25%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is 4891.T Expensive or Cheap?

P/E Ratio

4891.T trades at -5.50 times earnings. This suggests potential undervaluation.

-5.50

PEG Ratio

When adjusting for growth, 4891.T's PEG of -0.26 indicates potential undervaluation.

-0.26

Price to Book

The market values TMS Co., Ltd. at 2.06 times its book value. This may indicate undervaluation.

2.06

EV/EBITDA

Enterprise value stands at -8.58 times EBITDA. This is generally considered low.

-8.58

How Well Does 4891.T Make Money?

Net Profit Margin

For every $100 in sales, TMS Co., Ltd. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-31.82 in profit for every $100 of shareholder equity.

-31.82%

ROA

TMS Co., Ltd. generates $-35.04 in profit for every $100 in assets, demonstrating efficient asset deployment.

-35.04%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

4891.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.50

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.26

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.06

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

24.16

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.32

vs 25 benchmark

ROA

Return on assets percentage

-0.35

vs 25 benchmark

ROCE

Return on capital employed

-0.36

vs 25 benchmark

How 4891.T Stacks Against Its Sector Peers

Metric4891.T ValueSector AveragePerformance
P/E Ratio-5.5032.14 Better (Cheaper)
ROE-31.82%550.00% Weak
Net Margin0.00%30133.00% Weak
Debt/Equity0.000.56 Strong (Low Leverage)
Current Ratio24.165.70 Strong Liquidity
ROA-35.04%3.00% Weak

4891.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews TMS Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ